Counselors in Honoraville, AL Accepting Medicare
1 Counselors found. Showing 1 - 1
 Mrs. Karen A Sullins, M.S., LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 125 Sexton Dr, Honoraville, AL 36042 Phone: 334-301-1822 Fax: 334-770-1462 |
News Archive
Combining optical tomography with standard ultrasound imaging can help distinguish early-stage breast cancer
A new study shows that combining a technology called optical tomography with standard ultrasound imaging can help distinguish early-stage breast cancer from non-cancerous lesions-and potentially reduce the number of breast biopsies performed. The study appears in the October issue of the journal Radiology.
Combined therapy may lead to better outcomes in children with ADHD
Three studies to be published in the August 2016 issue of the Journal of the American Academy of Child and Adolescent Psychiatry report that combining two standard medications could lead to greater clinical improvements for children with attention-deficit/hyperactivity disorder (ADHD) than either ADHD therapy alone.
Illinois Back Institute offers non-surgical treatment for lower back pain
Chronic pain is terrifying. Sciatica and stenosis are two of the most common causes of persistent, debilitating back pain. Chicago resident Pedro Estrada suffered from extreme back pain that compromised his livelihood and soured his outlook on life. After taking time off from his job and consulting many doctors, he finally found relief with non-surgical treatment at the Illinois Back Institute.
Ophthotech announces data from Fovista Phase 2b trial on wet AMD
Ophthotech Corporation today announced that data from a large, prospective, randomized, controlled Phase 2b clinical trial of Ophthotech's Fovista anti-PDGF therapy (1.5 mg) in patients with neovascular age-related macular degeneration (wet AMD) will be presented during Retina Subspecialty Day at the American Academy of Ophthalmology Annual Meeting (AAO) on Sat., Nov. 10, 2012 at 9:15 a.m.
Affinium closes $15 million financing round
Affinium Pharmaceuticals announced today the closing of its $15 million financing. Investors participating in the financing include all three of Affinium's Series A investors, SV Life Sciences, Genesis Capital Partners and Forward Ventures, along with the addition of the Ontario Emerging Technologies Fund (OETF) to the syndicate.
› Verified 4 days ago